Newsletter | April 30, 2026

04.30.26 -- The Hidden Operational Cost Contained In Every Small Molecule Portfolio

SPONSOR

Pharmaceutical Online, Federal Equipment and Techceuticals bring you Virtual Pharma Expo - a one-day, themed event with live equipment demonstrations and presentations by leading experts from pharmaceutical equipment providers for aseptic fill/finish manufacturing & packaging - all from the convenience of your office! Whether you're looking to optimize your current processes or explore new technologies, this event will provide valuable knowledge and practical insights.

INDUSTRY INSIGHTS

Advancing ADCs With Expertise In Payloads And Linkers

Discover how integrated containment, high-potency expertise, advanced chromatography, and proven linker–payload process optimization can accelerate your ADC program.

Optimizing Mixing Efficiency: 5 Strategies For Industrial Manufacturers

Enhance production efficiency by aligning mixing technology with material viscosity. Implement automated controls and advanced powder injection to reduce errors and energy costs.

Concept To Market: Scaling And Manufacturing Semi-Solid Topical Drugs

Learn how formulation, processing, and scale‑up choices impact the stability, structure, and performance of semi‑solid topicals while ensuring consistent quality through development.

FEATURED EDITORIAL

The Hidden Operational Cost Contained In Every Small Molecule Portfolio

The volume of post-approval changes is rising and the manual approaches that have worked until now are no longer adequate. Get ahead of this to spend less and execute faster.

INDUSTRY INSIGHTS CONTINUED

Why Compliance-Driven CDMOs Win Sponsor Contracts

See how digital maturity and compliance excellence are reshaping CDMO competitiveness, as well as strategies that strengthen performance and accelerate tech transfers.

Combining AI And Experimental Strategies To Transform Drug Development

Watch how integrating AI-driven predictive modeling with well-designed experimental validation can help overcome development challenges and support accurate evaluation of API solid-state properties.

Technology For Taste-Masking In Oral Antimalarial Formulations

Drive forward the development and adoption of taste‑masked ASAQ micropellets so children in low‑resource settings can receive life‑saving antimalarial treatment that is effective and easy to take.

Balancing Limitations And Patient Perceptions For An Enhanced Experience

Explore an innovative sTW needle design reduces injection force and pain, enhancing comfort and ease for chronic patients while promoting long-term adherence through improved injection experiences.

Risk Considerations For Pyrogen Presence And The Need For The MAT Test

Tim Sandle, Head of Microbiology at BPL and visiting tutor of the University of College London & University of Manchester, answers questions about pyrogen and endotoxin tests, regulations, and more.

Choosing The Right Pharma CMO: The 3 Cs That Matter Most

Choosing a CMO is a strategic decision that shapes long‑term quality and scalability. Find out how a focused framework helps teams identify partners that can adapt and support growing portfolios.

Scientific Insights Into VHP Biodecontamination And BI Quality Management

VHP biodecontamination ensures aseptic manufacturing, but BI variability challenges validation. Addressing rogue BIs and regulatory shifts strengthens contamination control and process reliability.

Tablet Edge Erosion – Solutions For Friability

Addressing tablet edge erosion and friability involves adjusting formulation, tablet design, tooling, press setup, and operation speed to improve tablet robustness and reduce weight loss.

Embarking On A Successful Cleanroom Project: Conception To Delivery

Gain insight into how you can obtain comprehensive solutions for cleanroom projects that help you ensure regulatory compliance and operational efficiency.

High-Throughput Pyrogen Testing In A Multimode Microplate Reader

Examine a faster, high‑sensitivity approach to pyrogen detection that uses an NF‑κB reporter system to measure both endotoxin and non‑endotoxin contaminants to enable shorter workflows.

Successfully Producing Insoluble Proteins Using Inclusion Bodies

Review the pros and cons of soluble and insoluble processes, experiences with isolating, solubilizing, and properly re-folding, and strategies and innovation to improve insoluble processes.

SOLUTIONS

Amorphous Solid Dispersions: Pre-Clinical To Commercial Capabilities

Ensure The Safe And Efficient Development Of High Potent Drug Products

Make Traceability A Seamless Part Of Your Operations

Multiparticulates For Modified Release Systems

Evolve From Paper To Digital Operations Quickly And Simply

From Data Promises To Factory Results: Reality Leadership In Pharma

Connect With Pharmaceutical Online: